BeStock  
Stocks › Biotechnology › EPRX

Eupraxia Pharmaceuticals EPRX

US equityMarket cap rank #3682Biotechnology
$5.80 −$0.32 (-5.23%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $5.80 0.00%
Open$6.11
Prev close$6.12
Day range$5.69 – $6.42
Volume361.7K
Market cap$390.16M
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts9
Average target$17.25+197.4% vs. price
  • Buy 100%
Low $14.00Now $5.80Avg $17.25High $25.00

Recent rating changes

The last 20 actions on file set price targets from $11.00 to $25.00, averaging $15.06.

DateFirmRatingTarget
11 Nov 2026 H.C. Wainwright BUY $16.00
11 Nov 2026 Oppenheimer BUY $17.00
10 Nov 2026 Cantor Fitzgerald BUY $19.00
9 Nov 2026 RBC Capital BUY $14.00
20 Oct 2026 H.C. Wainwright BUY $11.00
16 Oct 2026 H.C. Wainwright BUY $11.00
15 Oct 2026 H.C. Wainwright BUY $11.00
7 Oct 2026 Cantor Fitzgerald BUY $19.00
1 Oct 2026 Wedbush BUY $17.00
1 Oct 2026 Bloom Burton BUY $14.00
1 Oct 2026 H.C. Wainwright BUY $11.00
30 Sep 2026 LifeSci Capital BUY $16.00
30 Sep 2026 William Blair BUY –
24 Sep 2026 Wedbush BUY $17.00
24 Sep 2026 Stifel BUY $25.00
21 Sep 2026 H.C. Wainwright BUY $11.00
27 Aug 2026 LifeSci Capital BUY $16.00
27 Aug 2026 William Blair BUY –
13 Aug 2026 H.C. Wainwright BUY $11.00
12 Aug 2026 William Blair BUY –

Discussion

No comments yet — be the first to weigh in on EPRX.

Sign in to join the discussion.

Scroll to Top